Compare EVAX & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVAX | NTWK |
|---|---|---|
| Founded | 2008 | 1997 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.7M | 35.5M |
| IPO Year | 2021 | 1998 |
| Metric | EVAX | NTWK |
|---|---|---|
| Price | $5.25 | $2.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.33 | N/A |
| AVG Volume (30 Days) | ★ 99.2K | 85.9K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | $7,650,000.00 | ★ $66,501,654.00 |
| Revenue This Year | $128.77 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $69.23 |
| Revenue Growth | ★ 132.17 | 7.70 |
| 52 Week Low | $1.20 | $2.14 |
| 52 Week High | $12.15 | $5.75 |
| Indicator | EVAX | NTWK |
|---|---|---|
| Relative Strength Index (RSI) | 46.34 | 26.36 |
| Support Level | $5.03 | $2.91 |
| Resistance Level | $6.12 | $3.16 |
| Average True Range (ATR) | 0.45 | 0.12 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 32.46 | 0.00 |
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.